These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12417268)

  • 1. Targeting the atherosclerotic process in clinical practice. A new look at established agents.
    Deanfield JE
    Atherosclerosis; 2002 Dec; 165(2):189-90. PubMed ID: 12417268
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-hypertensive strategies in patients with MEtabolic parameters, DIabetes mellitus and/or NephropAthy (the M E D I N A study).
    Spinar J; Vitovec J; Soucek M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):412-21. PubMed ID: 24026142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Angiotensin II type 1 antagonist suppress left ventricular hypertrophy and myocardial fibrosis in patient with end stage renal disease (ESRD)].
    Shibasaki Y; Nishiue T; Masaki H; Matsubara H; Iwasaka T
    Nihon Rinsho; 2002 Oct; 60(10):1992-8. PubMed ID: 12397697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A specialist in clinical hypertension critiques ALLHAT.
    Meltzer JI
    Am J Hypertens; 2003 May; 16(5 Pt 1):416-20. PubMed ID: 12745205
    [No Abstract]   [Full Text] [Related]  

  • 5. [Stable coronary artery disease--invasive treatment does not replace secondary prevention].
    Kettunen R; Lepojärvi M; Laine M
    Duodecim; 2012; 128(7):720-7. PubMed ID: 22612022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex Differences in Cardiac Medication Use Post-Catheterization in Patients Undergoing Coronary Angiography for Stable Angina with Nonobstructive Coronary Artery Disease.
    Galway S; Adatia F; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Sep; 26(9):976-983. PubMed ID: 28384013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin blockade in type 2 diabetes: what the new evidence tells us about renal and cardiac complications.
    Studney D
    Can J Cardiol; 2002 May; 18 Suppl A():3A-6A. PubMed ID: 12045787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Medication Use in Patients with Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease.
    Adatia F; Galway S; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Nov; 26(11):1185-1192. PubMed ID: 28384014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive agents and cardiovascular events in patients with coronary disease and normal blood pressure.
    Aboyans V; Lacroix P; Cassat C
    JAMA; 2005 Mar; 293(10):1187; author reply 1188-9. PubMed ID: 15755937
    [No Abstract]   [Full Text] [Related]  

  • 10. Antihypertensive agents and cardiovascular events in patients with coronary disease and normal blood pressure.
    Chikamori T; Tomiyama H; Yamashina A
    JAMA; 2005 Mar; 293(10):1187-8; author reply 1188-9. PubMed ID: 15755936
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of Statin Therapy on the Blood Pressure-Lowering Efficacy of a Single-Pill Perindopril/Amlodipine Combination in Hypertensive Patients with Hypercholesterolemia.
    Sirenko Y; Radchenko G;
    High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):85-93. PubMed ID: 28150140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients.
    Wu SC; Liu CP; Chiang HT; Lin SL
    Heart Vessels; 2004 Jan; 19(1):13-8. PubMed ID: 14685749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial.
    Praga M; Andrade CF; Luño J; Arias M; Poveda R; Mora J; Prat MV; Rivera F; Galceran JM; Ara JM; Aguirre R; Bernis C; Marín R; Campistol JM
    Nephrol Dial Transplant; 2003 Sep; 18(9):1806-13. PubMed ID: 12937228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary prevention therapies for coronary heart disease in patients with type 2 diabetes: an audit.
    Sharma KK; Guptha S; Gupta R
    J Assoc Physicians India; 2012 Apr; 60():28-30. PubMed ID: 23029739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients.
    el-Agroudy AE; Hassan NA; Foda MA; Ismail AM; el-Sawy EA; Mousa O; Ghoneim MA
    Am J Nephrol; 2003; 23(5):300-6. PubMed ID: 12904684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of diabetic nephropathy with nephrotic syndrome].
    Eguchi J; Wada J; Makino H
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():430-6. PubMed ID: 12430265
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of hypertension in elderly patients with coronary heart disease].
    Iwai K; Morimoto S; Matsumoto M
    Nihon Rinsho; 2005 Jun; 63(6):1033-9. PubMed ID: 15948387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amlodipine PREVENTS angina, not atherosclerosis.
    Williams C
    Pharmacotherapy; 2002 Mar; 22(3):400-1; discussion 401-2. PubMed ID: 11898898
    [No Abstract]   [Full Text] [Related]  

  • 19. Amlodipine better than lisinopril? How one randomized clinical trial ended fallacies from observational studies.
    Messerli FH; Staessen JA
    Hypertension; 2006 Sep; 48(3):359-61. PubMed ID: 16894055
    [No Abstract]   [Full Text] [Related]  

  • 20. [Angiotensin converting enzyme inhibitors and calcium antagonists: a synergistic action for a better prevention of cardiovascular events].
    Boutouyrie P
    Therapie; 2009; 64(4):241-8. PubMed ID: 19804704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.